Ridgetech Business Summary

Ridgetech Inc. (RDGT), formerly China Jo-Jo Drugstores, operates as a specialized wholesale distributor of pharmaceutical and healthcare products in the People’s Republic of China. The company’s revenue model is centered on B2B transaction fees and wholesale margins generated through three primary segments: Drug Wholesale, Online Pharmacy, and the cultivation of Traditional Chinese Medicine (TCM) herbs. Following a 2025 strategic restructuring, Ridgetech divested its retail pharmacy arm to focus on the acquisition-led growth of its Ridgeline and Allright (Hangzhou) subsidiaries, which facilitate distribution to clinics, pharmacies, and vendors via proprietary digital platforms and third-party marketplaces like Tmall and JD.com. Within the market, Ridgetech maintains a small-cap niche against dominant competitors such as JD Health International, 111 Inc. (YI), and Yifeng Pharmacy Chain, differentiating itself through its integrated TCM supply chain and lean wholesale-centric operational pivot. The executive leadership is led by Chief Executive Officer Ming "Frank" Zhao, who took the helm in February 2025 following a career that included a directorship at Greenland Technologies. Chairman Lingtao Kong provides strategic oversight, having joined the leadership structure after Ridgetech acquired his firm, Ridgeline International, a move that catalyzed the company’s shift toward wholesale distribution. The management team is rounded out by Chief Operating Officer Wei Hu and Secretary Liu Yan, with founder Lei Liu continuing to exert influence as a director and 10% beneficial owner. The board of directors, which includes experienced members like Caroline Wang and Jiangliang He, oversees a governance structure aimed at stabilizing the firm’s market position following its recent redomiciliation and brand transformation.